Wang Y, Hou L, Yang M, Fan J, Wang Y, Sun L
Medicine (Baltimore). 2023; 102(37):e35123.
PMID: 37713826
PMC: 10508570.
DOI: 10.1097/MD.0000000000035123.
Hammitt J, Tuncel T
J Risk Uncertain. 2023; :1-31.
PMID: 37360985
PMC: 10171170.
DOI: 10.1007/s11166-023-09406-2.
Stokes W, Xiong N, Liu Y, Higgins K, Tian S, Bradley J
Clin Lung Cancer. 2022; 23(3):e231-e237.
PMID: 35093293
PMC: 9106833.
DOI: 10.1016/j.cllc.2021.12.012.
Ayvaci M, Alagoz O, Ahsen M, Burnside E
Prod Oper Manag. 2019; 27(12):2313-2338.
PMID: 31031555
PMC: 6481963.
DOI: 10.1111/poms.12897.
Zhang C, Min L, Zhang L, Ma Y, Yang Y, Shou C
Tumour Biol. 2015; 37(2):2193-207.
PMID: 26349752
DOI: 10.1007/s13277-015-3938-5.
The real difficulty in improving concordance of clinical practice with guidelines.
Yao N, Recht A
Ann Transl Med. 2015; 3(6):85.
PMID: 25992384
PMC: 4416950.
DOI: 10.3978/j.issn.2305-5839.2015.03.51.
Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?.
Bertolaccini L, Terzi A, Ricchetti F, Alongi F
Ann Transl Med. 2015; 3(2):25.
PMID: 25738145
PMC: 4322166.
DOI: 10.3978/j.issn.2305-5839.2015.01.06.
Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada.
Louie A, Rodrigues G, Palma D, Senan S
Oncologist. 2014; 19(8):880-5.
PMID: 24951606
PMC: 4122471.
DOI: 10.1634/theoncologist.2013-0469.
Supporting shared decision making within the MobiGuide project.
Quaglini S, Shahar Y, Peleg M, Miksch S, Napolitano C, Rigla M
AMIA Annu Symp Proc. 2014; 2013:1175-84.
PMID: 24551401
PMC: 3900138.
[Indications for neoadjuvant or definitive radiochemotherapy in esophageal cancer of the highest evidence quality].
Guckenberger M
Strahlenther Onkol. 2012; 188(10):949-50.
PMID: 22903396
DOI: 10.1007/s00066-012-0213-1.
The Cost of Uncertain Life Span.
Edwards R
J Popul Econ. 2012; w14093.
PMID: 22368324
PMC: 3285408.
DOI: 10.1007/s00148-012-0405-0.
Clinical freedom, efficiency, and the Griffiths report.
Ludbrook A, Mooney G
Br Med J (Clin Res Ed). 2010; 288(6414):420-1.
PMID: 20742172
PMC: 1444230.
DOI: 10.1136/bmj.288.6414.420.
Stochastic dominance and medical decision making.
Leshno M, Levy H
Health Care Manag Sci. 2005; 7(3):207-15.
PMID: 15648563
DOI: 10.1023/b:hcms.0000039383.54736.65.
The promise of empirical research in the study of informed consent theory and practice.
Siminoff L, Caputo M, Burant C
HEC Forum. 2004; 16(1):53-71.
PMID: 15181671
DOI: 10.1023/b:hecf.0000031780.66472.f4.
Managing patients with inexplicable health problems.
Fischhoff B, Wessely S
BMJ. 2003; 326(7389):595-7.
PMID: 12637409
PMC: 1125482.
DOI: 10.1136/bmj.326.7389.595.
Differences in belief about likely outcomes account for differences in doctors' treatment preferences: but what accounts for the differences in belief?.
Rakow T
Qual Health Care. 2001; 10 Suppl 1:i44-9.
PMID: 11533438
PMC: 1765736.
DOI: 10.1136/qhc.0100044...
A treatment trade-off based decision aid for patients with locally advanced non-small cell lung cancer.
Brundage M, Feldman-Stewart D, Dixon P, Gregg R, Youssef Y, Davies D
Health Expect. 2001; 3(1):55-68.
PMID: 11281912
PMC: 5081084.
DOI: 10.1046/j.1369-6513.2000.00083.x.
[Statistically significant--also relevant for the patient?].
Lange S
Med Klin (Munich). 2000; 94 Suppl 2:22-4.
PMID: 10740398
DOI: 10.1007/BF03042023.
Benefit valuation in economic evaluation of cancer therapies. A systematic review of the published literature.
Brown J, Sculpher M
Pharmacoeconomics. 1999; 16(1):17-31.
PMID: 10539119
DOI: 10.2165/00019053-199916010-00003.
International differences in medical care practices.
McPherson K
Health Care Financ Rev. 1989; Spec No:9-20.
PMID: 10318366
PMC: 4195144.